Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hideaki Nakasone (Hideki Nakasone)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Venues

Bone marrow transplantation

Blood advances

International journal of hematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kento Umino, Kaoru Morita, Takashi Ikeda, Shin-Ichiro Kawaguchi, Takashi Nagayama, Shoko Ito, Daisuke Minakata, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Shun-Ichi Kimura, Shinichi Kako, Kazuteru Ohashi, Yukiyasu Ozawa, Yasuo Mori, Tetsuya Eto, Nobuhiro Hiramoto, Hirohisa Nakamae, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Hideaki Nakasone, Satoko Morishima, Yoshinobu Kanda
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect. Blood (2023)
Hideaki Nakasone
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. International journal of hematology (2023)
Yu Akahoshi, Hideaki Nakasone, Katsuto Takenaka, Satoshi Yamasaki, Momoko Nakamura, Kazuteru Ohashi, Masatsugu Tanaka, Yukiyasu Ozawa, Naoyuki Uchida, Takahide Ara, Hirohisa Nakamae, Shuichi Ota, Makoto Onizuka, Shingo Yano, Junji Tanaka, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Shinichi Kako, Masamitsu Yanada, Yasuyuki Arai
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. Blood advances (2023)
Hideaki Nakasone
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. International journal of hematology (2023)
Machiko Kusuda, Hideaki Nakasone, Kazuki Yoshimura, Yosuke Okada, Masaharu Tamaki, Akari Matsuoka, Takuto Ishikawa, Tomohiro Meno, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Ayumi Gomyo, Aki Tanihara, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients. British journal of haematology (2023)
Shun-Ichi Kimura, Hiroaki Shimizu, Takuya Miyazaki, Masatoshi Sakurai, Susumu Tanoue, Kensuke Kayamori, Chikako Ohwada, Kazuki Yoshimura, Hideaki Nakasone, Takuma Ohashi, Katsuhiro Shono, Takayoshi Tachibana, Kaoru Hatano, Keigo Okada, Yuta Kimura, Sachiko Seo, Noriko Doki, Masatsugu Tanaka, Yoshihiro Hatta, Satoshi Takahashi, Yoshinobu Kanda, null null
Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2022)
Yu Akahoshi, Yuma Tada, Emiko Sakaida, Machiko Kusuda, Kazuteru Ohashi, Naoyuki Uchida, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Ken-Ichi Matsuoka, Yukiyasu Ozawa, Makoto Onizuka, Junya Kanda, Yoshinobu Kanda, Yoshiko Atsuta, Hideaki Nakasone
Novel risk assessment for the intensity of conditioning regimen in elderly patients. Blood advances (2022)
Masaharu Tamaki, Hidenori Wada, Shun-Ichi Kimura, Naonori Harada, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Kazuhiro Ikegame, Masashi Sawa, Yuta Katayama, Shigesaburo Miyakoshi, Takahide Ara, Junya Kanda, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Yoshinobu Kanda, Kimikazu Yakushijin, Hideaki Nakasone
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors. Blood advances 6 (6) (2022)
Masaharu Tamaki, Shimpei Matsumi, Hideaki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Yosuke Okada, Machiko Kusuda, Kazuaki Kameda, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 57 (9) (2022)
Ryu Yanagisawa, Masaharu Tamaki, Reo Tanoshima, Yukiko Misaki, Naoyuki Uchida, Satoshi Koi, Takashi Tanaka, Yukiyasu Ozawa, Yayoi Matsuo, Masatsugu Tanaka, Kazuhiro Ikegame, Yuta Katayama, Ken-Ichi Matsuoka, Takahide Ara, Yoshinobu Kanda, Kimikazu Matsumoto, Takahiro Fukuda, Yoshiko Atsuta, Motohiro Kato, Hideaki Nakasone
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group. Hematological oncology (2022)
Yosuke Okada, Hideaki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Toshikuni Kawamura, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Aki Tanihara, Masaharu Tamaki, Shun-Ichi Kimura, Shinichi Kobayashi, Shinichi Kako, Fumihiko Kimura, Yoshinobu Kanda
Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome. Bone marrow transplantation 57 (5) (2022)
Junko Takeshita, Shun-Ichi Kimura, Hideaki Nakasone, Shunto Kawamura, Yuhei Nakamura, Masakatsu Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Masaharu Tamaki, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Hidenori Wada, Shinichi Kako, Yoshinobu Kanda
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society 23 (5) (2021)
Kaito Harada, Shun-Ichi Kimura, Shigeo Fuji, Yuho Najima, Kimikazu Yakushijin, Naoyuki Uchida, Makoto Onizuka, Kazuhiro Ikegame, Shingo Yano, Naoki Shingai, Ken-Ichi Matsuoka, Yasushi Onishi, Masashi Sawa, Satoru Takada, Toshiro Kawakita, Takahiro Fukuda, Junya Kanda, Yoshiko Atsuta, Hideaki Nakasone
Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 56 (9) (2021)
Hisayuki Yokoyama, Junya Kanda, Yuta Kawahara, Naoyuki Uchida, Masatsugu Tanaka, Satoshi Takahashi, Makoto Onizuka, Yuma Noguchi, Yukiyasu Ozawa, Yuna Katsuoka, Shuichi Ota, Takanori Ohta, Takafumi Kimura, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Hideaki Nakasone, Satoko Morishima
Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation. Bone marrow transplantation 56 (6) (2021)
Hideaki Nakasone, Shinichi Kako, Takehiko Mori, Satoshi Takahashi, Makoto Onizuka, Shin-Ichiro Fujiwara, Toru Sakura, Emiko Sakaida, Akira Yokota, Nobuyuki Aotsuka, Maki Hagihara, Nobuhiro Tsukada, Yoshihiro Hatta, Kensuke Usuki, Reiko Watanabe, Moritaka Gotoh, Shin Fujisawa, Shingo Yano, Heiwa Kanamori, Shinichiro Okamoto, Yoshinobu Kanda
Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone marrow transplantation 56 (6) (2021)
Masamitsu Yanada, Naoyuki Uchida, Tatsuo Ichinohe, Takahiro Fukuda, Junya Kanda, Yoshinobu Kanda, Yoshiko Atsuta, Hideaki Nakasone
Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (7) (2021)
Yu Akahoshi, Shun-Ichi Kimura, Yuma Tada, Toshihiro Matsukawa, Masaharu Tamaki, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Takuro Kuriyama, Ken-Ichi Matsuoka, Takashi Ikeda, Takafumi Kimura, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Murata, Seitaro Terakura, Hideaki Nakasone
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease. Blood advances (2021)
Hideaki Nakasone, Machiko Kusuda, Kiriko Terasako-Saito, Koji Kawamura, Yu Akahoshi, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Kazuki Yoshimura, Yukiko Misaki, Ayumi Gomyo, Kazuaki Kameda, Masaharu Tamaki, Aki Tanihara, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation. Communications biology 4 (1) (2021)
Kaito Harada, Shigeo Fuji, Sachiko Seo, Naoyuki Uchida, Toshiro Kawakita, Shingo Yano, Yukiyasu Ozawa, Satoshi Yoshioka, Yasushi Onishi, Yuma Noguchi, Makoto Onizuka, Yoshiko Matsuhashi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, null null, null null, Seitaro Terakura, Hideaki Nakasone
Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 56 (2) (2020)
Hideaki Nakasone, Koji Kawamura, Kimikazu Yakushijin, Akihito Shinohara, Masatsugu Tanaka, Kazuteru Ohashi, Shuichi Ota, Naoyuki Uchida, Takahiro Fukuda, Hirohisa Nakamae, Ken-Ichi Matsuoka, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshihiro Inamoto, Sachiko Seo, Fumihiko Kimura, Masao Ogata
BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient. Blood advances 3 (11) (2020)
Masamitsu Yanada, Takaaki Konuma, Shohei Mizuno, Masuho Saburi, Akihito Shinohara, Masatsugu Tanaka, Atsushi Marumo, Masashi Sawa, Naoyuki Uchida, Yukiyasu Ozawa, Makoto Onizuka, Satoshi Yoshioka, Hirohisa Nakamae, Tadakazu Kondo, Takafumi Kimura, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Hideaki Nakasone, Shingo Yano
Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia. Bone marrow transplantation 56 (2) (2020)
Hideaki Nakasone, Misato Kikuchi, Koji Kawamura, Yu Akahoshi, Miki Sato, Shunto Kawamura, Nozomu Yoshino, Junko Takeshita, Kazuki Yoshimura, Yukiko Misaki, Ayumi Gomyo, Aki Tanihara, Machiko Kusuda, Masaharu Tamaki, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans. Scientific reports 9 (1) (2019)
Hideaki Nakasone, Ken Tabuchi, Naoyuki Uchida, Yuju Ohno, Yoshiko Matsuhashi, Satoshi Takahashi, Yasushi Onishi, Makoto Onizuka, Hikaru Kobayashi, Takahiro Fukuda, Tatsuo Ichinohe, Minoko Takanashi, Koji Kato, Yoshiko Atsuta, Hiromasa Yabe, Yoshinobu Kanda
Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells? British journal of haematology 185 (1) (2018)
Hideaki Nakasone, Kiriko Terasako-Saito, Teiichi Hirano, Atsushi Wake, Seiichi Shimizu, Naoki Kurita, Etsuko Yamazaki, Kensuke Usuki, Kohei Akazawa, Junya Kanda, Koichiro Minauchi, Go Yamamoto, Shiori Tanimoto, Masaharu Kamoshita, Yasuhisa Yokoyama, Etsuo Miyaoka, Shuichi Ota, Shinichi Kako, Koji Izutsu, Yoshinobu Kanda
Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematological oncology 36 (1) (2017)

Hideaki Nakasone.css-eqlu8i{font-size:small;padding-left:4px;} (Hideki Nakasone)

Publication Activity (10 Years)

Top Topics

Top Venues

Hideaki Nakasone (Hideki Nakasone)